Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

IOVA

Iovance Biotherapeutics (IOVA)

Iovance Biotherapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:IOVA
DataHoraFonteTítuloCódigoCompanhia
24/05/202417:01GlobeNewswire Inc.Iovance Biotherapeutics to Present at Upcoming Conferences and EventsNASDAQ:IOVAIovance Biotherapeutics Inc
23/05/202418:00GlobeNewswire Inc.Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual MeetingNASDAQ:IOVAIovance Biotherapeutics Inc
17/05/202418:15Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:IOVAIovance Biotherapeutics Inc
17/05/202418:15GlobeNewswire Inc.Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)NASDAQ:IOVAIovance Biotherapeutics Inc
09/05/202418:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IOVAIovance Biotherapeutics Inc
09/05/202417:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IOVAIovance Biotherapeutics Inc
09/05/202417:01GlobeNewswire Inc.Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate UpdatesNASDAQ:IOVAIovance Biotherapeutics Inc
01/05/202407:01GlobeNewswire Inc.Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024NASDAQ:IOVAIovance Biotherapeutics Inc
30/04/202407:01GlobeNewswire Inc.Iovance Biotherapeutics to Present at Upcoming ConferencesNASDAQ:IOVAIovance Biotherapeutics Inc
24/04/202417:01GlobeNewswire Inc.Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual MeetingNASDAQ:IOVAIovance Biotherapeutics Inc
06/03/202420:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IOVAIovance Biotherapeutics Inc
04/03/202408:30GlobeNewswire Inc.Iovance Biotherapeutics Announces FDA has Lifted Clinical Hold on the IOV-LUN-202 Registrational Trial in Non-Small Cell Lung CancerNASDAQ:IOVAIovance Biotherapeutics Inc
28/02/202418:01GlobeNewswire Inc.Iovance Biotherapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates NASDAQ:IOVAIovance Biotherapeutics Inc
22/02/202410:45GlobeNewswire Inc.Iovance Biotherapeutics to Host Fourth Quarter and Full-Year 2023 Financial Results Conference Call and Webcast on Wednesday, February 28, 2024NASDAQ:IOVAIovance Biotherapeutics Inc
21/02/202418:44Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IOVAIovance Biotherapeutics Inc
20/02/202408:30GlobeNewswire Inc.Iovance Biotherapeutics, Inc. Announces Pricing of $211 Million Underwritten Offering of Common StockNASDAQ:IOVAIovance Biotherapeutics Inc
16/02/202417:38GlobeNewswire Inc.Iovance Biotherapeutics to Host Conference Call and Webcast on Friday, February 16, 2024NASDAQ:IOVAIovance Biotherapeutics Inc
16/02/202417:19GlobeNewswire Inc.Iovance’s AMTAGVI™ (lifileucel) Receives U.S. FDA Accelerated Approval for Advanced MelanomaNASDAQ:IOVAIovance Biotherapeutics Inc
14/02/202408:16Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:IOVAIovance Biotherapeutics Inc
28/12/202309:27IH Market NewsWall Street Highlights: Amazon to Introduce Ads on Prime Video, JD.com Raises Salaries in 2024, and MoreNASDAQ:IOVAIovance Biotherapeutics Inc
27/12/202309:54Dow Jones NewsIovance Shares Fall Premarket As FDA Places Study On Hold After Patient DeathNASDAQ:IOVAIovance Biotherapeutics Inc
27/12/202309:00GlobeNewswire Inc.Iovance Biotherapeutics Announces Clinical Program Update for LN-145 in Non-Small Cell Lung CancerNASDAQ:IOVAIovance Biotherapeutics Inc
07/11/202318:01GlobeNewswire Inc.Iovance Biotherapeutics Reports Third Quarter and Year-to-Date 2023 Financial Results and Corporate UpdatesNASDAQ:IOVAIovance Biotherapeutics Inc
31/10/202317:01GlobeNewswire Inc.Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2023 Financial Results Conference Call and Webcast on Tuesday, November 7, 2023NASDAQ:IOVAIovance Biotherapeutics Inc
31/10/202310:05GlobeNewswire Inc.Iovance Biotherapeutics to Present Clinical and Pre-Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapies at Society for Tumor Immunotherapy of Cancer’s (SITC) 38th Annual MeetingNASDAQ:IOVAIovance Biotherapeutics Inc
16/10/202309:15GlobeNewswire Inc.Iovance Biotherapeutics Announces Clinical Data for Lifileucel in Advanced Mucosal Melanoma at the European Society for Medical Oncology (ESMO) CongressNASDAQ:IOVAIovance Biotherapeutics Inc
14/09/202319:10GlobeNewswire Inc.U.S. Food and Drug Administration Updates Prescription Drug User Fee Act (PDUFA) Action Date for Lifileucel for the Treatment of Advanced MelanomaNASDAQ:IOVAIovance Biotherapeutics Inc
07/09/202308:31GlobeNewswire Inc.Iovance Biotherapeutics to Present at 2023 Wells Fargo Healthcare ConferenceNASDAQ:IOVAIovance Biotherapeutics Inc
08/08/202317:01GlobeNewswire Inc.Iovance Biotherapeutics Reports Second Quarter and First Half 2023 Financial Results and Corporate UpdatesNASDAQ:IOVAIovance Biotherapeutics Inc
25/07/202317:01GlobeNewswire Inc.Iovance Biotherapeutics to Present Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapy at IASLC 2023 World Conference on Lung CancerNASDAQ:IOVAIovance Biotherapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:IOVA